05/15/2026
What do you think? Excited for the next-gen Dexcom? I'm an Eversense girl, myself, but this is newsy.
Dexcom has officially unveiled its next-generation continuous glucose monitor, the Dexcom G8, during the company’s 2026 Investor Day presentation.
The new CGM platform is expected to be 50% smaller than the current G7 while touting improved accuracy, reliability, and connectivity.
Dexcom says the G8 will use an entirely new silicon chip, updated algorithms, and adaptive sensing technology designed to reduce inaccurate readings and better adjust to each user’s physiology over time.
Company leaders also hinted at future "multi-analyte" capabilities, including ketone and potassium monitoring. Dexcom plans to submit the G8 to the FDA in 2027, with a commercial launch anticipated in late 2027 or early 2028.